Dow Up 0.07% Nasdaq Up 0.61%

Arrowhead Research Corp. (ARWR)

-NasdaqGS
5.78 Down 0.06(1.03%) 4:00PM EST
|After Hours : 5.80 Up 0.02 (0.35%) 6:35PM EST
Prev Close:5.84
Open:5.80
Bid:N/A
Ask:6.80 x 300
1y Target Est:17.75
Beta:3.04
Next Earnings Date:N/A
Day's Range:5.73 - 5.93
52wk Range:5.47 - 27.63
Volume:1,881,177
Avg Vol (3m):4,206,370
Market Cap:305.81M
P/E (ttm):N/A
EPS (ttm):-1.15
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARWR

Comparison

Symbol% ChgMkt Cap
ARWRDown 1.03%305.81M
APNT 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,765.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-15) :-0.74
Quarterly EPS Est (Dec-14) :-0.23
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-1.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Arrowhead Research Corporation, a biopharmaceutical company, develops targeted RNAi therapeutics in the United States. The company’s product candidate comprise ARC-520, an RNAi-based therapeutic that has completed a Phase 1 clinical trial for... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback